Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Total Non-Current Liabilities (2021 - 2026)

Updated

Pasithea Therapeutics' Total Non-Current Liabilities was $32,341 in Q2 2026, down 65.5% from $93,741 a year earlier and down 38.9% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Pasithea Therapeutics came in at $46,871, down 71.1% from FY2024.

  • Total Non-Current Liabilities shows a four-year compound annual growth rate of -57.6% (FY2021 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $162,172 in FY2024 (+92.2%), $84,366 in FY2023 (-89.5%), $804,207 in FY2022 (-44.6%) and $1.45 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Total Non-Current Liabilities in data going back to Q3 2021.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for four straight quarters, with an average decline of 17.1% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q3 2022 (growth of 147.2%); the worst was Q1 2024 (a decline of 92.7%).
  • Per Business Quant data, KTTA's Total Non-Current Liabilities in the three quarters before Q2 2026 was $52,966 (Q1 2026), $46,871 (Q4 2025) and $46,871 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - 32,341.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32,341.00
Mar 31, 2026 52,966.00
Dec 31, 2025 46,871.00
Sep 30, 2025 46,871.00
Jun 30, 2025 93,741.00
Mar 31, 2025 85,305.00
Dec 31, 2024 162,172.00
Sep 30, 2024 163,578.00
Jun 30, 2024 93,272.00
Mar 31, 2024 57,650.00
Dec 31, 2023 84,366.00
Sep 30, 2023 239,876.00
Jun 30, 2023 330,139.00
Mar 31, 2023 787,630.00
Dec 31, 2022 804,207.00
Sep 30, 2022 1.31 Mn
Jun 30, 2022 604,048.00
Mar 31, 2022 667,503.00
Dec 31, 2021 1.45 Mn
Sep 30, 2021 528,096.00
API Access

Pasithea Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KTTA&period=max&api_key=YOUR_API_KEY